Lancashire Teaching Hospitals NHS Foundation Trust is one of the United Kingdom's NHS Foundation Trusts. It provides healthcare for people in the Preston area and surrounding area in northwest England.

During the past decade, Lancashire Teaching Hospitals NHS Foundation Trust conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lancashire Teaching Hospitals NHS Foundation Trust" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Lancashire Teaching Hospitals NHS Foundation Trust" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "University College, London" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lancashire Teaching Hospitals NHS Foundation Trust" #1 collaborator was "King's College London" with 2 trials as a collaborator, "Lancashire Care NHS Foundation Trust" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Newcastle-upon-Tyne Hospitals NHS Trust" with 2 trials as a collaborator and "University of Oxford" with 2 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Lancashire Teaching Hospitals NHS Foundation Trust" are "Prostate Cancer" (3 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Colorectal Cancer" (2 trials), "Giant Cell Arteritis" (2 trials) and "Melanoma (Skin)" (2 trials). Many other conditions were trialed in "Lancashire Teaching Hospitals NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Lancashire Teaching Hospitals NHS Foundation Trust" are "Drug" (14 trials), "Other" (6 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "A package of interventions" (1 trials), "Active management" (1 trials), "Administration of Live attenuated influenza vaccine (LAIV)" (1 trials) and "Androgen Deprivation Therapy (ADT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lancashire Teaching Hospitals NHS Foundation Trust" are 23 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Lancashire Teaching Hospitals NHS Foundation Trust". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Lancashire Teaching Hospitals NHS Foundation Trust, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lancashire Teaching Hospitals NHS Foundation Trust, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

Lancashire Teaching Hospitals NHS Foundation Trust has several departments that took part in Clinical trials: "Rosemere Cancer Centre at Royal Preston Hospital" - 20 trials